Regeneron Pharmaceuticals, Inc.(REGN)
NASDAQ
$742.12
3.40 (0.46%)

Regeneron Pharmaceuticals, Inc.(REGN)Earnings Date, History & Expected Move
NASDAQ

REGN is scheduled to report on Oct 30, 2026, usually before the market opens. Analysts expect EPS of $16.17.

Next report
Oct 30, 2026
In 22 days · usually before open
EPS beat rate
83%
10 of 12 quarters
Avg move after earnings
±4.9%
Up 58% of the time · last 12
Options-implied move
—
No reliable options quote yet

EPS: Actual vs Estimate

Reported earnings per share against the consensus estimate, last 12 quarters.

Green = beat or met, red = missed, amber = our data sources disagree on beat vs miss for that quarter.

Stock Reaction After Earnings

Close-to-close move in the first session that reflected each report.

Dashed lines mark the average actual move (±4.9%).

Did the stock rise after good news?

"Beat" means the company earned more than analysts expected. Here is what the stock did the next day.

When it beat expectations
10 reports
When it missed expectations
2 reports

In plain words: it beat expectations 10 times, but the stock still fell 4 of those 10 times.

Report by report
  • Jul '26
    Beat
    ▲ +6.2%
  • Apr '26
    Beat
    ▼ -6.2%
  • Jan '26
    Beat
    ▼ -1.1%
  • Oct '25
    Beat
    ▲ +11.8%
  • Aug '25
    Beat
    ▲ +2.5%
  • Apr '25
    Missed
    ▼ -6.9%
  • Feb '25
    Beat
    ▲ +4.5%
  • Oct '24
    Beat
    ▼ -9.2%
  • Aug '24
    Beat
    ▲ +1.3%
  • May '24
    Missed
    ▲ +3.8%
  • Feb '24
    Beat
    ▼ -1.3%
  • Nov '23
    Beat
    ▲ +3.5%

Only reports with a clear beat or miss and a known price reaction are counted. A beat does not guarantee a gain.

After an EPS beat
+1.2%
average next-day move · up 60% of 10 times
After an EPS miss
-1.5%
average next-day move · up 50% of 2 times

Why did REGN fall after beating earnings?

Beating or missing estimates is only part of the story. These are the measurable things that stand out for each surprising reaction.

REGN beat EPS estimates in 10 quarters, and the stock still closed lower the next day 4 times.

  • Apr 29, 2026EPS beat +6.4%stock -6.2% next day
    • It opened 3.6% lower as soon as trading resumed.
  • Jan 30, 2026EPS beat +6.4%stock -1.1% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

  • Oct 31, 2024EPS beat +6.5%stock -9.2% next day
    • It opened 5.2% lower as soon as trading resumed.
  • Feb 2, 2024EPS beat +10.3%stock -1.3% next day
    • It opened 1.4% higher, but sellers took over and it closed -1.3%.

Rose despite an EPS miss (1 of 2)

  • May 2, 2024EPS missed -5.4%stock +3.8% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

These are patterns visible in estimates and prices, not confirmed causes. Information only, not investment advice.

Was REGN's earnings move already priced in?

Stocks often move in the weeks before a report. This compares that run-up with what happened after the report.

Avg move in the month before
-1.0%
last 12 reports
Higher before the report
33%
of the time
After a run-up of 3%+
Fell 25%
4 reports, avg +4.5%
After a drop of 3%+
Rose 40%
5 reports, avg -1.8%

“Month before” is the move over the 20 trading days up to the last close before the report. “Priced in” means the good news may already be in the price. A run-up of 5% or more is treated as large.

Before vs after each report

Grey: how the stock moved in the 20 trading days before the report. Green or red: how it moved the day after.

Past reports only: this shows what happened, not what will happen.

Does REGN hold its opening gap after earnings?

A gap is how far the stock opens from the previous close. A gap fades when the stock gives back at least half of it by the end of the day.

In 8 reports REGN opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 8 times (50%), and fully reversed 3 times. Gaps up faded 2 of 3; gaps down recovered 2 of 5.

  • Apr 29, 2026Held
    Opened -3.6%, closed -6.2%
  • Oct 28, 2025Held
    Opened +4.6%, closed +11.8%
  • Aug 1, 2025Faded
    Opened +6.9%, closed +2.5%
  • Apr 29, 2025Held
    Opened -8.0%, closed -6.9%
  • Feb 4, 2025Reversed
    Opened -2.5%, closed +4.5%
  • Oct 31, 2024Held
    Opened -5.2%, closed -9.2%
  • Aug 1, 2024Reversed
    Opened -1.7%, closed +1.3%
  • Feb 2, 2024Reversed
    Opened +1.4%, closed -1.3%

Gap = opening price vs the previous close. Close = the end of the first session that reflected the report. Reports without a clear opening time are left out.

What the history says

  • REGN has beaten EPS estimates in 5 straight quarters.
  • It fell after 4 of its 10 EPS beats (40%): beating estimates has not been enough on its own.

REGN earnings history

Last 12 reported quarters with the stock's reaction.

Swipe sideways to see every column →

Report dateTimeEPS est.EPS actualSurprise1-day move3-day move
Jul 30, 2026Before open$10.21$14.29+40.0%+6.17%+9.18%
Apr 29, 2026Before open$8.90$9.47+6.4%-6.21%-4.15%
Jan 30, 2026Before open$10.75$11.44+6.4%-1.07%+1.30%
Oct 28, 2025Before open$9.64$11.83+22.7%+11.82%+11.74%
Aug 1, 2025Before open$8.44$12.89+52.7%+2.46%+4.48%
Apr 29, 2025Before open$8.48$8.22-3.1%-6.87%-3.41%
Feb 4, 2025Before open$11.19$12.07+7.9%+4.53%+8.28%
Oct 31, 2024Before open$11.70$12.46+6.5%-9.17%-10.18%
Aug 1, 2024Before open$10.62$11.56+8.9%+1.29%-0.73%
May 2, 2024Before open$10.10$9.55-5.4%+3.78%+6.11%
Feb 2, 2024Before open$10.75$11.86+10.3%-1.32%-2.09%
Nov 2, 2023Before open$10.78$11.59+7.5%+3.48%+5.20%

Consensus for the next report: EPS $16.17, revenue $4.63B.

REGN Earnings FAQ

Answers computed from Regeneron Pharmaceuticals, Inc.'s reported history

REGN is scheduled to report on Oct 30, 2026, usually before the market opens. Analysts expect EPS of $16.17.

Over the last 12 quarters with a usable EPS surprise, REGN beat the consensus estimate 10 times (83%), missed 2 and landed in line 0. It has beaten estimates in each of the last 5 counted quarters.

Across its last 12 quarters with a measured reaction, REGN moved an average of ±4.9% in the first session after reporting. It closed higher 58% of the time; the largest gain was 11.8% and the largest drop -9.2%.

REGN fell in the first session after 4 of its last 10 EPS beats (40%). A beat that was already priced in, or weaker guidance, can send a stock lower.

Across its last 12 quarters with price data, REGN moved an average of -1.0% in the 20 trading sessions before reporting and was higher in 33% of them. After a run-up of 3% or more (4 quarters), it fell the next day 25% of the time, averaging +4.5%. After a drop of 3% or more (5 quarters), it rose the next day 40% of the time, averaging -1.8%. This describes past reports; it is not a forecast.

In 8 reports REGN opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 8 times (50%), and fully reversed 3 times. A fade means the opening move was partly undone during the first session.

How we calculate these numbers

Reported EPS and estimates come from Yahoo Finance; report times, upcoming dates and revenue come from Finnhub. The 1-day move is the close-to-close change over the first session that reflects the report (the report-day close for after-close reports, the prior close for pre-market reports); reactions are left blank when the report time is unknown or looks inconsistent. The expected move is the price of the nearest at-the-money straddle that expires after the report divided by the share price, shown only when the quotes are liquid. Quarters where the two data sources disagree on beat versus miss are shown but never counted. Information only, not investment advice.